Correction: Short leukocyte telomeres predict 25-year Alzheimer’s disease incidence in non-APOE ε4-carriers

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
Correction: Short leukocyte telomeres predict 25-year Alzheimer’s disease incidence in non-APOE ε4-carriers ; volume:16 ; number:1 ; day:16 ; month:2 ; year:2024 ; pages:1 ; date:12.2024
Alzheimer's research & therapy ; 16, Heft 1 (16.2.2024), 1, 12.2024

Creator
Hackenhaar, Fernanda Schäfer
Josefsson, Maria
Adolfsson, Annelie Nordin
Landfors, Mattias
Kauppi, Karolina
Hultdin, Magnus
Adolfsson, Rolf
Degerman, Sofie
Pudas, Sara
Contributor
SpringerLink (Online service)

DOI
10.1186/s13195-024-01388-w
URN
urn:nbn:de:101:1-2404240841195.648603828165
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:47 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Hackenhaar, Fernanda Schäfer
  • Josefsson, Maria
  • Adolfsson, Annelie Nordin
  • Landfors, Mattias
  • Kauppi, Karolina
  • Hultdin, Magnus
  • Adolfsson, Rolf
  • Degerman, Sofie
  • Pudas, Sara
  • SpringerLink (Online service)

Other Objects (12)

Short leukocyte telomeres predict 25-year Alzheimer's disease incidence in non-APOE ε4-carriers

Short leukocyte telomeres predict 25-year Alzheimer's disease incidence in non-APOE ε4-carriers

Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease

Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease

Author Correction: Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease

Author Correction: Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease

APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease

APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease

The genetic risk of Alzheimer’s disease beyond APOE ε4: systematic review of Alzheimer’s genetic risk scores

The genetic risk of Alzheimer’s disease beyond APOE ε4: systematic review of Alzheimer’s genetic risk scores

The influence of APOE ε4 on the pTau interactome in sporadic Alzheimer’s disease

The influence of APOE ε4 on the pTau interactome in sporadic Alzheimer’s disease

The relationship between complement factor C3, APOE ε4, amyloid and tau in Alzheimer’s disease

The relationship between complement factor C3, APOE ε4, amyloid and tau in Alzheimer’s disease

Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer’s disease

Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer’s disease

APOE ε4, Alzheimer’s disease neuropathology and sleep disturbance, in individuals with and without dementia

APOE ε4, Alzheimer’s disease neuropathology and sleep disturbance, in individuals with and without dementia

CSF biomarkers for Alzheimer's pathology and the effect size of APOE ε4

CSF biomarkers for Alzheimer's pathology and the effect size of APOE ε4

Evidence that an APOE ε4 'double whammy' increases risk for Alzheimer's disease

Evidence that an APOE ε4 'double whammy' increases risk for Alzheimer's disease

Brain APOE expression quantitative trait loci-based association study identified one susceptibility locus for Alzheimer’s disease by interacting with APOE ε4

Brain APOE expression quantitative trait loci-based association study identified one susceptibility locus for Alzheimer’s disease by interacting with APOE ε4

Related objects